Exact Mass: 311.1651966
Exact Mass Matches: 311.1651966
Found 500 metabolites which its exact mass value is equals to given mass value 311.1651966,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Leonurine
Leonurine is a trihydroxybenzoic acid. Leonurine is a natural product found in Leonotis leonurus and Leonurus sibiricus with data available. Leonurine is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.
Pretilachlor
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3117
nalorphine
C19H21NO3 (311.15213560000007)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
IMAZAQUIN
C17H17N3O3 (311.12698520000004)
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7950; ORIGINAL_PRECURSOR_SCAN_NO 7948 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7948; ORIGINAL_PRECURSOR_SCAN_NO 7947 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3770; ORIGINAL_PRECURSOR_SCAN_NO 3769 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3779; ORIGINAL_PRECURSOR_SCAN_NO 3778 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3762; ORIGINAL_PRECURSOR_SCAN_NO 3761 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3761; ORIGINAL_PRECURSOR_SCAN_NO 3760 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7928; ORIGINAL_PRECURSOR_SCAN_NO 7927 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7919; ORIGINAL_PRECURSOR_SCAN_NO 7918 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7962; ORIGINAL_PRECURSOR_SCAN_NO 7957 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3745; ORIGINAL_PRECURSOR_SCAN_NO 3744 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3711
(-)-Thebaine
C19H21NO3 (311.15213560000007)
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics (-)-Thebaine is a minor constituent of opiu
Machete
CONFIDENCE standard compound; INTERNAL_ID 560; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10349; ORIGINAL_PRECURSOR_SCAN_NO 10345 CONFIDENCE standard compound; INTERNAL_ID 560; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10330; ORIGINAL_PRECURSOR_SCAN_NO 10326 CONFIDENCE standard compound; INTERNAL_ID 560; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10216; ORIGINAL_PRECURSOR_SCAN_NO 10211 CONFIDENCE standard compound; INTERNAL_ID 560; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10284; ORIGINAL_PRECURSOR_SCAN_NO 10281 CONFIDENCE standard compound; INTERNAL_ID 560; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10304; ORIGINAL_PRECURSOR_SCAN_NO 10299 CONFIDENCE standard compound; INTERNAL_ID 560; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10247; ORIGINAL_PRECURSOR_SCAN_NO 10245 D010575 - Pesticides > D006540 - Herbicides D009676 - Noxae > D002273 - Carcinogens D016573 - Agrochemicals
Isothebaine
C19H21NO3 (311.15213560000007)
(R)-Pronuciferine
C19H21NO3 (311.15213560000007)
Alkaloid from Nelumbo nucifera (East India lotus). (R)-Pronuciferine is found in many foods, some of which are poppy, coffee and coffee products, sacred lotus, and cherimoya. (R)-Pronuciferine is found in cherimoya. (R)-Pronuciferine is an alkaloid from Nelumbo nucifera (East India lotus
Acronydine
C18H17NO4 (311.11575220000003)
An organic heterotetracyclic compound that is 3H-furo[2,3-b]pyrano[3,2-f]quinoline carrying a gem-dimethyl group at position 3 as well as two methoxy substituents at positions 5 and 11.
Domoic acid
C15H21NO6 (311.13688060000004)
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Isodomoic acid F is found in mollusks. Isodomoic acid F is isolated from mussels. Isolated from mussels. Isodomoic acid F is found in mollusks.
17beta-Hydroxy-3-methoxyestra-1,3,5(10)-triene-17-carbonitrile
Isodomoic acid A
C15H21NO6 (311.13688060000004)
An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,5-dien-2-yl group at position 4. It is isolated from the red alga, Chondria armata. D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins
Tolazamide
C14H21N3O3S (311.13035560000003)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4274; ORIGINAL_PRECURSOR_SCAN_NO 4272 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4225; ORIGINAL_PRECURSOR_SCAN_NO 4223 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4245; ORIGINAL_PRECURSOR_SCAN_NO 4243 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4316; ORIGINAL_PRECURSOR_SCAN_NO 4314 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4224; ORIGINAL_PRECURSOR_SCAN_NO 4220 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8447; ORIGINAL_PRECURSOR_SCAN_NO 8445 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8470; ORIGINAL_PRECURSOR_SCAN_NO 8469 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8494; ORIGINAL_PRECURSOR_SCAN_NO 8491 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8497; ORIGINAL_PRECURSOR_SCAN_NO 8496 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8468; ORIGINAL_PRECURSOR_SCAN_NO 8463 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8506; ORIGINAL_PRECURSOR_SCAN_NO 8504
N2N2-Dimethylguanosine
CONFIDENCE standard compound; INTERNAL_ID 311 N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.
N2,N2-Dimethylguanosine
N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. The mean levels of urinary N2,N2-Dimethylguanosine in the patients with colorectal cancer are significantly higher than those in patients with intestinal villous adenoma or the healthy adults (PMID 15991285). N2,N2-Dimethylguanosine has been identified in the human placenta (PMID: 32033212). N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.
Norisodomesticine
C18H17NO4 (311.11575220000003)
Norisodomesticine is found in herbs and spices. Norisodomesticine is an alkaloid from the leaves Laurus nobilis (bay laurel). Alkaloid from the leaves Laurus nobilis (bay laurel). Norisodomesticine is found in tea, sweet bay, and herbs and spices.
N-[2-Methoxy-2-(4-methoxyphenyl)ethyl]cinnamide
C19H21NO3 (311.15213560000007)
N-[2-Methoxy-2-(4-methoxyphenyl)ethyl]cinnamide is found in fruits. N-[2-Methoxy-2-(4-methoxyphenyl)ethyl]cinnamide is isolated from Aegle marmelos (bael). Isolated from Aegle marmelos (bael). N-[2-Methoxy-2-(4-methoxyphenyl)ethyl]cinnamide is found in fruits.
Piperettine
C19H21NO3 (311.15213560000007)
Alkaloid from the dried fruits of Piper nigrum (pepper). Piperettine is found in herbs and spices and pepper (spice). Piperettine is found in herbs and spices. Piperettine is an alkaloid from the dried fruits of Piper nigrum (pepper
Annocherine B
C18H17NO4 (311.11575220000003)
Annocherine B is found in fruits. Annocherine B is an alkaloid from Annona cherimola (cherimoya Alkaloid from Annona cherimola (cherimoya). Annocherine B is found in fruits.
Lansamide 4
C19H21NO3 (311.15213560000007)
Lansamide 4 is found in fruits. Lansamide 4 is a constituent of Clausena lansium (wampee) Constituent of Clausena lansium (wampee). Lansamide 4 is found in fruits.
Launobine
C18H17NO4 (311.11575220000003)
Launobine is found in herbs and spices. Launobine is an alkaloid from Laurus nobilis (bay laurel
(S)-Nandigerine
C18H17NO4 (311.11575220000003)
(S)-Nandigerine is found in herbs and spices. (S)-Nandigerine is an alkaloid from Laurus nobilis (bay laurel). Alkaloid from Laurus nobilis (bay laurel). (S)-Nandigerine is found in tea, sweet bay, and herbs and spices.
Arginylhistidine
Arginylhistidine is a dipeptide composed of arginine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Histidylarginine
Histidylarginine is a dipeptide composed of histidine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
(+)-Norushinsunine N-oxide
C18H17NO4 (311.11575220000003)
(+)-Norushinsunine N-oxide is an alkaloid from Cananga odorata (ylang ylang
1,7-Dimethylguanosine
1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216) [HMDB] 1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216).
2-trans,4-cis-Decadienoylcarnitine
2-trans,4-cis-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an (2E,4Z)-deca-2,4-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-trans,4-cis-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-trans,4-cis-decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular 2-trans,4-cis-decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Tolazamide
C14H21N3O3S (311.13035560000003)
Tolazamide is only found in individuals that have used or taken this drug. It is a sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide. [PubChem]Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
Lansimide 3
C19H21NO3 (311.15213560000007)
Lansimide 3 is found in fruits. Lansimide 3 is a constituent of Clausena lansium (wampee)
Pyrrobutamine
C20H22ClN (311.14406820000005)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use Pyrrobutamine is an H1-antihistamine.
(2E,4Z)-Decadienoylcarnitine
(2E,4Z)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an (2E,4Z)-decadienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,4Z)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,4Z)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (2E,4Z)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3,8)-Decadienoylcarnitine
(3,8)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-3,8-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3,8)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3,8)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (3,8)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2,6)-Decadienoylcarnitine
(2,6)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-2,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2,6)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2,6)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (2,6)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3,6)-Decadienoylcarnitine
(3,6)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-3,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3,6)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3,6)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (3,6)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(6,8)-Decadienoylcarnitine
(6,8)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-6,8-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6,8)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (6,8)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (6,8)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3,5)-Decadienoylcarnitine
(3,5)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-3,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3,5)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3,5)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (3,5)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2,8)-Decadienoylcarnitine
(2,8)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-2,8-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2,8)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2,8)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (2,8)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(4,6)-Decadienoylcarnitine
(4,6)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-4,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4,6)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4,6)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (4,6)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(5,8)-Decadienoylcarnitine
(5,8)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-5,8-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5,8)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (5,8)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (5,8)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2,7)-Decadienoylcarnitine
(2,7)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-2,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2,7)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2,7)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (2,7)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(4,7)-Decadienoylcarnitine
(4,7)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-4,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4,7)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4,7)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (4,7)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(5,7)-Decadienoylcarnitine
(5,7)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-5,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5,7)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (5,7)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (5,7)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(4,8)-Decadienoylcarnitine
(4,8)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-4,8-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4,8)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4,8)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (4,8)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3,7)-Decadienoylcarnitine
(3,7)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-3,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3,7)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3,7)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (3,7)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2,5)-Decadienoylcarnitine
(2,5)-Decadienoylcarnitine is an acylcarnitine. More specifically, it is an deca-2,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2,5)-Decadienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2,5)-Decadienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (2,5)-Decadienoylcarnitine is elevated in the blood or plasma of individuals with 2,4-dienoyl-coenzyme a reductase deficiency (PMID: 2332510, PMID: 15344554, PMID: 19578400). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937) and schizophrenia (PMID: 31161852). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-(((4,7-Dimethyl-1,3-benzoxazol-2-yl)methyl)amino)-5-ethyl-6-methylpyridin-2(1H)-one
5-(N,N-Hexamethylene)amiloride
D000970 - Antineoplastic Agents
Vephylline
C13H21N5O4 (311.15934660000005)
Butofilolol
C17H26FNO3 (311.18966180000007)
1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one
C17H17N3O3 (311.12698520000004)
CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].
Chloramitriptyline
C20H22ClN (311.14406820000005)
10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-piperidinoethyl)-
C18H21N3S (311.14561060000005)
10-((1-Methyl-3-piperidyl)methyl)-10H-pyrido(3,2-b)(1,4)benzothiazine
C18H21N3S (311.14561060000005)
Dienogest
Dothiepin sulfoxide
C19H21NOS (311.13437760000005)
Lethidrone
C19H21NO3 (311.15213560000007)
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
Noberastine
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Xanthinol
C13H21N5O4 (311.15934660000005)
(2S,3S,4S)-4-[(6S)-6-Carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid
C15H21NO6 (311.13688060000004)
Actinodaphnine
C18H17NO4 (311.11575220000003)
Actinodaphnine is a member of the class of compounds known as aporphines. Aporphines are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof. Actinodaphnine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Actinodaphnine can be found in sweet bay, which makes actinodaphnine a potential biomarker for the consumption of this food product.
Actinodaphnine
C18H17NO4 (311.11575220000003)
An organic heteropentacyclic compound 6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinoline bering additional hydroxy and methoxy substituents at positions 10 and 11 respectively.
Dienogest
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D000970 - Antineoplastic Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3284
(1Z)-4-Isopropyl-1-(2-methylpropylidene)-2H-pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione
adiphenine
C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Feruloyl dehydrotyramine (isomer of 1654)
C18H17NO4 (311.11575220000003)
Annotation level-3
(7aS)-10-methoxy-(7ar)-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-8t-ol|Michelanugin|Michelanugine
C18H17NO4 (311.11575220000003)
1,3,5-Trihydroxy-4-prenyl-9,10-dihydroacridine-9-one
C18H17NO4 (311.11575220000003)
(-)-beta-8-methylpseudoanibacanine|(8S,13aS)-form-8-Methylpseudoanibacanine
C19H21NO3 (311.15213560000007)
1,2-dimethoxy-3-hydroxy-5-oxonoraporphine
C18H17NO4 (311.11575220000003)
1,10-dimethoxy-6-methyl-aporphan-11-ol|isothebaine
C19H21NO3 (311.15213560000007)
(-)-2-Hydroxy-3,8-dimethoxypavinane
C19H21NO3 (311.15213560000007)
15,16-methanediyldioxy-3alpha-methoxy-11a-homo-erythrina-1,6-diene|Schelhammeridin|Schelhammeridine
C19H21NO3 (311.15213560000007)
2-Methylbutyric acid 2-[(2-hydroxyethyl)amino]-1,5-dimethyl-4-methoxy-6-oxo-2,4-cyclohexadien-1-yl ester
8,9,10-Trimethoxy-4,5-dihydro-7H-pyrrolo[3,2,1-de]phenanthridine-7-one
C18H17NO4 (311.11575220000003)
1-methyl-2-(3-hydroxy-3,7-dimethyl-octa-1,6-dienyl)quinolin-4(1h)-one
Dehydro-isolongistrobin|Dehydroisolongistrobin
C17H17N3O3 (311.12698520000004)
2-[2-(3,4-dimethoxyphenyl)ethyl]-1-methyl-3,4-dihydro-2H-quinoline
1,2-Dihydro-1-(alpha-hydroxy-4-methoxybenzyl)-6,7-methylenedioxyisoquinoline|1,2-Dihydro-1-(hydroxy-p-methoxybenzyl)-6,7-methylenedioxyisoquinoline
C18H17NO4 (311.11575220000003)
5,6-dimethoxy-2-(3-methoxyphenyl)-1H-quinolin-4-one
C18H17NO4 (311.11575220000003)
5,7-Dimethoxy-4-(4-methoxyphenyl)-2(1H)-quinolinone
C18H17NO4 (311.11575220000003)
(S)-3-((2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl)methyl)piperazine-2,5-dione|talathermophilin E
(Z)-4,6-dimethoxy-7-[(3-methylbuta-1,3-dienyloxy)]furo[2,3-b]quinoline|leptanoine B
C18H17NO4 (311.11575220000003)
5,7,8-trimethoxy-2,3-dihydroindeno[1,2,3-ij]isoquinoline-6-ol|caulophylline E
C18H17NO4 (311.11575220000003)
methyl 1-((2-methyl carbamate)ethyl)-beta-carboline-3-carboxylate
C17H17N3O3 (311.12698520000004)
2,9,10-trimethoxy-4H-pyrrolo[3,2,1-de]phenanthridin-7(5H)-one|lycosprenine
C18H17NO4 (311.11575220000003)
(S)-Actinodaphnine|(??)-Actinodaphnine
C18H17NO4 (311.11575220000003)
(+/-)-1-hydroxy-2,9-dimethoxyaporphine|2,9-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-1-ol|dl-Lirinine|Lirinin|Orientinine
C19H21NO3 (311.15213560000007)
(-)-norannuradhapurine|(R)-Norannuradhapurine|Norannuradhapurine
C18H17NO4 (311.11575220000003)
15,16-ethane-1,2-diyldioxy-3beta-methoxy-erythrina-1,6-diene|Erythralin
C19H21NO3 (311.15213560000007)
(-)-alpha-8-methylanibacanine|(8R,13aS)-form-8-Methylanibacanine
C19H21NO3 (311.15213560000007)
Fissistigine A
C18H17NO4 (311.11575220000003)
Fissistigine A is a natural product found in Xylopia laevigata, Fissistigma oldhamii, and Xylopia parviflora with data available.
thebaine
C19H21NO3 (311.15213560000007)
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics relative retention time with respect to 9-anthracene Carboxylic Acid is 0.549 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.537 IPB_RECORD: 2881; CONFIDENCE confident structure
C18H21N3O2_(1Z)-4-Isopropyl-1-(2-methylpropylidene)-2H-pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione
Domoic acid
C15H21NO6 (311.13688060000004)
An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,4-dien-2-yl group at position 4. It is produced by the diatomic algal Pseudo-nitzschia. It is an analogue of kainic acid and a neurotoxin which causes amnesic shellfish poisoning (ASP). D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents
1-(2-methylpropylidene)-4-(propan-2-yl)-1H,2H,3H,4H,6H-piperazino[2,1-b]quinazoline-3,6-dione
Feruloyl dehydrotyramine (isomer of 1655)
C18H17NO4 (311.11575220000003)
Annotation level-3
Pretilachlor
Precursor ion is [M+H]+ of 37Cl-containing molecule.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
17-hydroxy-3-oxo-, (17??)-19-Norpregna-5(10),9(11)-diene-21-nitrile
1-Propanamine, N,N-dimethyl-3-(5-oxidodibenzo[b,e]thiepin-11(6H)-ylidene)-, (E)- (9CI)
C19H21NOS (311.13437760000005)
(-)-Thebaine
C19H21NO3 (311.15213560000007)
Lansimide 3
C19H21NO3 (311.15213560000007)
Launobine
C18H17NO4 (311.11575220000003)
Norjuzipjine
C18H17NO4 (311.11575220000003)
Nandigerine
C18H17NO4 (311.11575220000003)
Piperettine
C19H21NO3 (311.15213560000007)
(+)-Norushinsunine N-oxide
C18H17NO4 (311.11575220000003)
Lansamide 4
C19H21NO3 (311.15213560000007)
A 3-hydroxy-6-methoxy-1-methyl-4,5-diphenyl-2-piperidinone in which positions 3,4,5 and 6 have S,S,R,R stereochemistry, respectively.
Annocherine B
C18H17NO4 (311.11575220000003)
Aegle marmelos alkaloid D
C19H21NO3 (311.15213560000007)
CAR 10:2
2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid Methyl ester
3-[3-(4-methylphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid
C18H17NO4 (311.11575220000003)
3-(Dimethylamino)-1,2-bis(4-methoxyphenyl)-2-propen-1-one
C19H21NO3 (311.15213560000007)
4-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]morpholine
C18H18FN3O (311.14338300000003)
(S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
C19H21NOS (311.13437760000005)
1-(3,4-Methylenedioxyphenyl)-2-pyrrolidino-1-pentanone hydrochloride
C16H22ClNO3 (311.12881319999997)
(2R,4R)-3-Benzyloxycarbonyl-4-methyl-2-phenyl-1,3-oxazolidin-5-one
C18H17NO4 (311.11575220000003)
(5s)-3,4,5,6-tetrahydro-5-phenyl-n-(benzyloxycarbonyl)-4(h)-1,4-oxazin-2-one
C18H17NO4 (311.11575220000003)
5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-
N,N-dimethyl-1-spiro[1,3-dioxolane-2,11-6H-benzo[c][1]benzoxepine]-4-ylmethanamine
C19H21NO3 (311.15213560000007)
3-[[2-(2,3-dihydro-1H-inden-5-yloxy)acetyl]amino]benzoic acid
C18H17NO4 (311.11575220000003)
Butofilolol
C17H26FNO3 (311.18966180000007)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
tert-butyl 4-[(6-chloropyridin-3-yl)methyl]piperazine-1-carboxylate
2-[(1-ADAMANTYLCARBONYL)AMINO]-4-(METHYLTHIO)BUTANOIC ACID
C16H25NO3S (311.15550600000006)
N-[(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]-Carbamic acid 1,1-dimethylethyl ester
C16H19F2NO3 (311.13329280000005)
2-(N,N-Dimethylsulfamoyl)phenylboronic acid. pinacol ester
C14H22BNO4S (311.13625220000006)
2-(3-(tert-butoxycarbonyl)-3-azaspiro[5.5]undecane-9-yl)acetic acid
(1R, 2R)-Pseudoephedrine-(S)-2-methylhydrocinnamamide
(4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)PHENYL)METHANOL
C18H22BNO3 (311.16926520000004)
3-(N,N-Dimethylsulfamoyl)phenylboronic acid, pinacol ester
C14H22BNO4S (311.13625220000006)
N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
C14H22BNO4S (311.13625220000006)
Piperazine, 2-Methyl-4-(4-nitrophenyl)-1-(phenylmethyl)-, (2R)-
N-(3-methoxyphenyl)-2-[4-(2-methylpropyl)phenyl]propanamide
N-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide
C14H22BNO4S (311.13625220000006)
buta-1,3-diene,methyl 2-methylprop-2-enoate,prop-2-enenitrile,styrene
N-(4-METHOXYPHENYL)-2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-2-YL)ACETAMIDE
C17H17N3O3 (311.12698520000004)
butyl prop-2-enoate,2-methylidenebutanedioic acid,prop-2-enenitrile
C15H21NO6 (311.13688060000004)
Benzyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside
C15H21NO6 (311.13688060000004)
(S)-(-)N-CARBOMETHOXY-ALPHA,ALPHA-DIPHENYL-2-PYRROLIDINEMETHANOL,98
C19H21NO3 (311.15213560000007)
tert-butyl 4-fluoro-4-(methylsulfonyloxymethyl)piperidine-1-carboxylate
(2R,4S)-ethyl 5-([1,1-biphenyl]-4-yl)-4-amino-2-Methylpentanoate
3,5-DICHLOROBENZENE-1-CARBOXIMIDAMIDEHYDROCHLORIDE
N-Cbz-3,4-Dihydro-1H-isoquinolinecarboxylic acid
C18H17NO4 (311.11575220000003)
Talsupram
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
3-[(3-methoxyphenyl)methyl]-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione
C19H21NO3 (311.15213560000007)
2-METHYLPHENYL 2-ACETAMIDO-2-DEOXY-β-D-GLUCOPYRANOSIDE
C15H21NO6 (311.13688060000004)
1-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methoxy-2H-isoquinolin-6-one
C18H17NO4 (311.11575220000003)
3-Piperidinecarboxylicacid, 4-oxo-1-(2-phenylethyl)-, ethyl ester, hydrochloride (1:1)
C16H22ClNO3 (311.12881319999997)
Cyclobenzaprine hydrochloride
C20H22ClN (311.14406820000005)
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant with activity on the central nervous system.
3-(4-chloro-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester
C16H22ClNO3 (311.12881319999997)
(2,4,6-trimethylphenyl)methyl 2-benzamidoacetate
C19H21NO3 (311.15213560000007)
N-BENZYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDIN-2-AMINE
N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide
C14H22BNO4S (311.13625220000006)
6-O-tert-butyl 3-O-ethyl 5,7-dihydro-4H-thieno[2,3-c]pyridine-3,6-dicarboxylate
5-(4-Methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane hydroc hloride
2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride
C16H22ClNO3 (311.12881319999997)
1-ethenylpyrrolidin-2-one,ethyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid
2-CBZ-AMINO-INDAN-2-CARBOXYLIC ACID
C18H17NO4 (311.11575220000003)
Femoxetine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D049990 - Membrane Transport Modulators D000890 - Anti-Infective Agents
tert-butyl 4-(2-chlorophenoxy)piperidine-1-carboxylate
C16H22ClNO3 (311.12881319999997)
1-BENZYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-1H-PYRIDIN-2-ONE
C18H22BNO3 (311.16926520000004)
N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide
C15H22FN3O3 (311.16451140000004)
Fomocaine
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
ETHYL 2-METHYL-5-OXO-4-PHENYL-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBOXYLATE
C19H21NO3 (311.15213560000007)
(R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid
C18H17NO4 (311.11575220000003)
S-(+)-N,N-DIMETHYL-3-(1-NAPHTHLENYLOXY)-3-(2-THIENYL)-PROPANAMINE
C19H21NOS (311.13437760000005)
Acetamide,N-(2-chlorophenyl)-2-[[2-(diethylamino)ethyl]ethylamino]-
(4-(1-(((Benzyloxy)carbonyl)amino)cyclopropyl)phenyl)boronic acid
2-(BENZYLOXY)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE
C18H22BNO3 (311.16926520000004)
1-ISOPENTYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
C17H17N3O3 (311.12698520000004)
6-Benzyloxypyridine-3-boronic acid pinacol ester
C18H22BNO3 (311.16926520000004)
2H-1-Benzopyran-2-one,3-[2-(diethylamino)ethyl]-7-hydroxy-4-methyl-, hydrochloride (1:1)
C16H22ClNO3 (311.12881319999997)
1-(6,7-DIMETHOXY-1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-ETHANONE
C19H21NO3 (311.15213560000007)
DL-5-Benzoylamino-5-benzyl-4-oxo-1,3-dioxane
C18H17NO4 (311.11575220000003)
(S)-Di-tert-butyl2-cyanopiperazine-1,4-dicarboxylate
Ethyl 3-(dibenzylamino)-2-oxopropanoate
C19H21NO3 (311.15213560000007)
3-AMINO-N,N-DIETHYL-4-PIPERIDIN-1-YL-BENZENESULFONAMIDE
1-N-BOC-4-(3-CHLOROPHENYL)-4-HYDROXYPIPERIDINE
C16H22ClNO3 (311.12881319999997)
2,3(1H)-Isoquinolinedicarboxylic acid, 3,4-dihydro-, 2-(phenylmethyl) ester
C18H17NO4 (311.11575220000003)
Butanoic acid, 4-[bis(phenylmethyl)amino]-, ethyl ester
2-((benzyloxy)carbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid
C18H17NO4 (311.11575220000003)
Leonurine
Leonurine is a trihydroxybenzoic acid. Leonurine is a natural product found in Leonotis leonurus and Leonurus sibiricus with data available. Leonurine is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.
(2S)-1-Amino-3-{[3-fluoro-4-(4-morpholinyl)phenyl]amino}-2-propanyl acetate
C15H22FN3O3 (311.16451140000004)
(R)-(+)-N-CARBOMETHOXY-ALPHA, ALPHA-DIPHEN YL-2-PYRROLIDINEMETHANOL
C19H21NO3 (311.15213560000007)
1-{4-[(2-Ethoxyethoxy)methyl]phenoxy}-3-(isopropylamino)-2-propanol
1-Benzylpyridin-2(1H)-one-5-boronic acid pinacol ester
C18H22BNO3 (311.16926520000004)
(S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine
C19H21NOS (311.13437760000005)
Benzenamine, 5-chloro-2-(dodecyloxy)-
C18H30ClNO (311.20158000000004)
3-Oxobutanoic acid 2-[phenyl(phenylmethyl)amino]ethyl ester
C19H21NO3 (311.15213560000007)
trans-1-(tert-butoxycarbonyl)-4-(cyclohexylmethyl)pyrrolidine-3-carboxylic acid
N-(furan-2-ylmethyl)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanimine
C18H22BNO3 (311.16926520000004)
metahexamide
C14H21N3O3S (311.13035560000003)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
ETHYL 5-BOC-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-2-CARBOXYLATE
3-Pyrrolidinecarboxylic acid, 4-(3-methoxyphenyl)-1-(phenylmethyl)-
C19H21NO3 (311.15213560000007)
N,3-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
C14H22BNO4S (311.13625220000006)
Benzyl 2-Acetamido-2-deoxy-β-D-glucopyranoside
C15H21NO6 (311.13688060000004)
2-Benzyloxypyridine-3-boronic acid pinacol ester
C18H22BNO3 (311.16926520000004)
4-BOC-2-(4-CHLOROPHENYL)-2-METHYLMORPHOLINE
C16H22ClNO3 (311.12881319999997)
N6-(2-Hydroxyethyl)adenosine
N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,styrene
2-Methoxyoestra-1,3,5(10),16-tetraene-3-carboxamide
10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-piperidinoethyl)-
C18H21N3S (311.14561060000005)
Benzoic acid, p-hydroxy-, (p-(diethylamino)benzylidene)hydrazide
Val-pro-pro
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors A tripeptide composed of L-valine and two L-proline units joined by peptide linkages. H-Val-Pro-Pro-OH, a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM. H-Val-Pro-Pro-OH, a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM. H-Val-Pro-Pro-OH, a milk-derived proline peptides derivative, is an inhibitor of Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM.
4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine
C17H17N3O3 (311.12698520000004)
Ambutonium
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
(R)-6-Propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,10,11-triol
C19H21NO3 (311.15213560000007)
N-[2-(2-methoxyphenoxy)ethyl]-2,3-dihydro-1H-indene-5-carboxamide
C19H21NO3 (311.15213560000007)
N-{(E)-[4-(dimethylamino)phenyl]methylidene}-2-(3-methylphenoxy)acetohydrazide
1-phenyl-N-(3-propan-2-yloxypropyl)-4-pyrazolo[3,4-d]pyrimidinamine
1,7,7-Trimethyl-4-[(2-methyl-2,3-dihydroindol-1-yl)-oxomethyl]-2-bicyclo[2.2.1]heptanone
N-[2-(3,4-Dimethoxy-phenyl)-ethyl]-3-phenyl-acrylamide
C19H21NO3 (311.15213560000007)
(S)-3-Oxo-N-(2-oxotetrahydrofuran-3-yl)tridecanamide
Pyrrobutamine
C20H22ClN (311.14406820000005)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use
N-{2-[(4-Cyano-1,1-biphenyl-4-YL)oxy]ethyl}-N-hydroxy-N-methylurea
C17H17N3O3 (311.12698520000004)
(2s)-2-{[3-(3-Aminophenyl)imidazo[1,2-B]pyridazin-6-Yl]amino}-3-Methylbutan-1-Ol
(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide
(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
C15H21NO6 (311.13688060000004)
1-(4-(4-chlorophenyl)-3-phenylbut-2-enyl)pyrrolidine
C20H22ClN (311.14406820000005)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use
Butanex
D010575 - Pesticides > D006540 - Herbicides D009676 - Noxae > D002273 - Carcinogens D016573 - Agrochemicals
N2,N2-Dimethylguanosine (incomplete stereochemisrty)
N-(7-carboxy-7-demethylgeranyl)-L-glutamate
C15H21NO6-2 (311.13688060000004)
(3R,4R,5R,6R)-3-amino-6-[2-hydroxy-2-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]ethyl]oxane-2,4,5-triol
(3Z)-N,N-dimethyl-3-(5-oxo-6H-benzo[c][1]benzothiepin-11-ylidene)propan-1-amine
C19H21NOS (311.13437760000005)
(3Z)-3-(5-chloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenylidene)-N,N-dimethylpropan-1-amine
C20H22ClN (311.14406820000005)
(2S,3S,4S)-4-[(6S)-6-Carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid
C15H21NO6 (311.13688060000004)
2-(3,4-Dimethylphenyl)-5-ethyl-5-phenyl-1,2,4-triazolidine-3-thione
C18H21N3S (311.14561060000005)
3-(2,3-dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)phenol
1-(4-Morpholinyl)-2-(4-phenylphenoxy)-1-propanone
C19H21NO3 (311.15213560000007)
N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-2-(1-methyl-3-indolyl)-2-oxoacetamide
N-[2-(2-fluorophenyl)ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[5,1-b]quinazolin-9-amine
C17H18FN5 (311.15461600000003)
3-(((4-(2-Methoxyphenyl)-1-piperazinyl)imino)methyl)phenol
5-(2-Ethoxyphenyl)-3-(2-methoxy-6-methyl-3-pyridinyl)-1,2,4-oxadiazole
C17H17N3O3 (311.12698520000004)
6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
2-Methoxy-6-[[(1-propyl-5-benzimidazolyl)amino]methyl]phenol
(2-Nitro-benzylidene)-(4-pyridin-2-yl-piperazin-1-yl)-amine
N-[4-[[(3,4-dimethylanilino)-oxomethyl]amino]phenyl]-N-methylacetamide
3-Chloro-1-cyclohexyl-4-(4-methyl-1-piperazinyl)pyrrole-2,5-dione
4-(dimethylamino)-N-[1-(3-methoxyphenyl)ethylidene]benzohydrazide
3-(4-Ethyl-1-piperazinyl)-5-methylpyridazino[3,4-b][1,4]benzoxazine
2-[[(4-Methyl-2-thiazolyl)amino]-oxomethyl]-1-pyrrolidinecarboxylic acid 2-methylpropyl ester
C14H21N3O3S (311.13035560000003)
1-(4-methylphenyl)ethanone N-(2-phenylethyl)thiosemicarbazone
C18H21N3S (311.14561060000005)
1-(4-Methoxyphenyl)-1-methyl-3-(1-methyl-5-benzotriazolyl)urea
2-[(E)-[4-(Dimethylamino)phenyl]methylideneamino]oxy-N-(4-methylphenyl)acetamide
N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate
4-(4-phenylmethoxyphenoxy)-N-prop-2-enyl-1-butanamine
Ibogaine(1+)
A tertiary ammonium ion resulting from the protonation of the tertiary amino group of ibogaine.
(4S)-4-[(2E,4Z)-2,4-Decadienoyloxy]-4-(trimethylammonio)butanoate
1-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2S,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
1-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-3-(4-fluorophenyl)urea
C15H22FN3O3 (311.16451140000004)
(3S,4S,5R,6R)-3-hydroxy-6-methoxy-1-methyl-4,5-diphenylpiperidin-2-one
C19H21NO3 (311.15213560000007)
N-butyl-N(2)-[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]-L-serinamide
(2S)-2-Amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridinyl)propyl]propanamide
1-(4-Fluorophenyl)-2-phenyl-3-(1-piperidinyl)-1-propanone
N-ethyl-N-(3-methylphenyl)-N-(7H-purin-1-ium-6-yl)propane-1,3-diamine
(2S)-2-amino-N-[(2S)-1-oxo-1-[2-(2,4,5-trihydroxyphenyl)ethylamino]propan-2-yl]propanamide
(3S)-3-[(2E,4Z)-deca-2,4-dienoyl]oxy-4-(trimethylazaniumyl)butanoate
2-[(8S,13R,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile
(+)-Pronuciferine
C19H21NO3 (311.15213560000007)
An isoquinoline alkaloid isolated from Berberis coletioides.
Butachlore
D010575 - Pesticides > D006540 - Herbicides D009676 - Noxae > D002273 - Carcinogens D016573 - Agrochemicals
CFM 2
C17H17N3O3 (311.12698520000004)
CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].
(2E,4Z)-decadienoylcarnitine
An O-acylcarnitine having (2E,4Z)-decadienoyl as the acyl substituent.
3-Hydroxy-6-methoxy-1-methyl-4,5-diphenyl-2-piperidinone
C19H21NO3 (311.15213560000007)
A member of the class of piperidones that is 1-methylpiperidin-2-one in which a hydrogen at positions 3,4,5 and 6 has been replaced by hydroxy, phenyl, phenyl and methoxy groups, respectively.
(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol
C19H21NO3 (311.15213560000007)
O-decadienoylcarnitine
An O-acylcarnitine in which the acyl group specified is decadienoyl in which the positions of the double bonds is unspecified..
O-decadienoyl-L-carnitine
An O-acyl-L-carnitine that is L-carnitine having decadienoyl group as the acyl substituent in which the positions of the two double bonds are unspecified.
N(2),N(2)-Dimethylguanosine
A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups.
2′-O-Methyl-8-methyl guanosine
2′-O-Methyl-8-methyl guanosine (m8Gm) is a Z-form RNA stabilizer. 2′-O-Methyl-8-methyl guanosine can markedly stabilize the Z-RNA at low salt conditions[1]. m8Gm-contained oligonucleotides stabilize the Z-DNA under low salt conditions[2].